Samuraciclib CAS 1805833-75-3

Deskripsyon Product:

Non pwodwi: Samuraciclib CAS 1805833-75-3

 

Sinonim:

(3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pirimidin-5-il)amino)methyl)piperidin -3-ol;

PPDA-001;

ICEC0942 (CT7001) Baz gratis.

 

Pwopriyete Chimik ak Fizik

Aparans: poud solid

Esè: NLT98%

Dansite: 1.30 g / cm3

pwopriyete chimik: idrosolubl nan DMSO

 

Aplikasyon: Samuraciclib se yon pisan, selektif, ATP-konpetitif ak oralman aktif CDK7 inhibiteur, ak yon IC5 0 nan 41 nM. Samuraciclib montre 45-, 15-, 230- ak 30-pliye selektivite sou CDK1, CDK2 (IC50 nan 578 nM), CDK5 ak CDK9, respektivman. Samuraciclib anpeche kwasans liy selil kansè nan tete ak valè GI50 ant 0.2-0.3 µM. Samuraciclib gen efè anti-timè.

 

Nou ka bay touSamuraciclib entèmedyè:

3-isopropylpyrazolo[1,5-a]pirimidin-5,7-dyol 771510-25-9;

5,7-dikloro-3-izopropylpyrazolo[1,5-a]pirimidin 771510-32-8;

tert-butil benzyl(5-kloro-3-isopropylpyrazolo[1,5-a]pirimidin-7-il)karbamat 1092444-33-1;

(3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pirimidin-5-il)amino)methyl)piperidin -3-ol 1805833-75-3;

(3R,4R)-tèt-Butil4-(aminometil)-3-(methoxymethoxy)piperidin-1-karboksilat 1805790-20-8;

N-Boc-4-(idroksimetil)-1,2,3,6-tetrahydropyridine 203663-26-7.

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: samuraciclib cas 1805833-75-3, manifaktirè, founisè, faktori, achte, nan stock

• On: Deutivacaftor CAS 1413431-07-8
• Pwochen: 3-Methyl-2-pirolidon CAS 2555-05-7